Eckert & Ziegler awards prizes to young nuclear medicine researchers

Press Release

Eckert & Ziegler awards prizes to young nuclear medicine researchers

Berlin, 13 October 2015. This year's Eckert & Ziegler Abstract Award went to five nuclear medicine specialists from Germany, the Netherlands, the United Kingdom and USA at the congress of the European Association of Nuclear Medicine (EANM) in Hamburg. The prizes were awarded for research work in the fields of oncological and neurological diagnostics.

The competition, which is run by Eckert & Ziegler AG in cooperation with the EANM and awards prizes of EUR1,000 each, was held for the eighth time. A jury of seven EANM members chose the following five laureates from a total of 617 entries:

Erik Aarntzen, Netherlands: Tc-99m-CXCL8 SPECT to image disease activity in inflammatory bowel disease

Ana Denis-Bacelar, United Kingdom: Metastatic control probability in patients with prostate cancer metastatic to bone treated 186Re-HEDP

Matthias Eder, Germany: A phage display derived stabilised bicyclic peptide targeting MMP-14 shows high imaging contrast in small animal PET imaging

Elsmarieke van de Giessen, Netherlands: Blunted striatal dopamine release in cannabis dependence

Reinier Hernandez, USA: Synergistically Enhanced Tumor Uptake via Dual-Targeting of CD105 and EGFR Using a "Click" Heterodimer

"With its Travel Award, Eckert & Ziegler assists young scientists in making their research results in the field of medical imaging available to a broad public," explained Dr. André Heß, Member of the Executive Board of Eckert & Ziegler AG and Head of the Radiopharma Segment.

Further information about the Eckert & Ziegler Travel Award can be found at: http://www.ezag.com/home/about-us/social-engagement/abstract-award.html

Photo:
http://www.ezag.com/home/press/press-releases/detail/article/eckert-ziegler-awards-prizes-to-young-nuclear-medicine-researchers-1.html

About Eckert & Ziegler
Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), with approximately 700 employees, is one the world's largest providers of isotope technology for radiation therapy and nuclear medicine.
Contributing to saving lives.

For further information or questions, please contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com